SCHEMBL6176103

SCHEMBL6176103

CCOC(=O)CN(Cc1ccccc1)Cc1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.53
MAPK1 P28482 2/20 0.52
MEP1A Q16819 1/20 0.52
MEP1B Q16820 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
TDP1 Q9NUW8 2/20 0.50
LTA4H P09960 1/20 0.50
ALDH1A1 P00352 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TSHR P16473 2/20 0.48
RNF4 P78317 1/20 0.48
ALOX5 P09917 1/20 0.48
PTGES O14684 1/20 0.47
TAS2R14 Q9NYV8 1/20 0.47
TAS2R8 Q9NYW2 1/20 0.47
CXCR3 P49682 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL254781 0.90 ALDH1A1 (0.53) MEP1BTP53MAPTLTA4HALDH1A1
SCHEMBL30622744 0.89 ALDH1A1 (0.51) ACHEMAPK1MEP1AMEP1BTP53
SCHEMBL3184733 0.88 ALDH1A1 (0.54) TP53MAPTLTA4HALDH1A1L3MBTL1
SCHEMBL2061494 0.88 MEP1B (0.56) ACHEMAPK1MEP1AMEP1BALDH1A1
SCHEMBL20574911 0.87 ALDH1A1 (0.50) ACHEMAPK1MEP1AMEP1BTP53
SCHEMBL2338811 0.87 MEP1B (0.58) ACHEMAPK1MEP1AMEP1BMAPT
SCHEMBL6175982 0.86 BCHE (0.50) ACHEMEP1BTP53LTA4HALDH1A1
SCHEMBL27790214 0.85 ALDH1A1 (0.64) TP53MAPTTDP1ALDH1A1L3MBTL1
SCHEMBL9833066 0.85 ALDH1A1 (0.48) ACHEMEP1BTP53MAPTLTA4H
SCHEMBL7227133 0.84 PPID (0.47) MEP1BTP53MAPTLTA4HALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1061921-A4 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2005-03-30 EP disclosed
US-20020147334-A1 Vitronectin Receptor Antagonists SMITHKLINE BEECHAM CORPORATION 2002-10-10 US disclosed
EP-1061921-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-27 EP disclosed
WO-1999045927-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147334-A1 Vitronectin Receptor Antagonists ADGRF1, FN1, CALCR ACHE 3149/4885MAPK1 1097/4885MEP1A 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.